Hosts: Vincent Racaniello, Alan Dove, Rich Condit, and Kathy Spindler
The TWiV team reviews a meta-analysis of clinical trial reports on using Tamiflu for influenza, and suggestions on how to rescue US biomedical research from its systemic flaws.
Click arrow to play
Download TWiV 282 (75 MB .mp3, 104 min)
Subscribe (free): iTunes, RSS, email
Links for this episode
- World Malaria Day
- Review of oseltamivir clinical trials (Brit Med J)
- Effectiveness of Tamiflu questioned (NHS choices)
- Tamiflu campaign (Brit Med J)
- Rescuing US biomedical research (PNAS)
- Letters read on TWiV 282
Weekly Science Picks
Alan – Northampton Airport
Vincent – Particle Fever
Kathy – Turn iPhone into microscope
Rich – My favorite science gifs
Listener Pick of the Week
Nathan – The Ascent of Man (YouTube)
Send your virology questions and comments (email or mp3 file) to twiv@microbe.tv
April 25 th is also World penguin day (and my birthday!). So all in all a pretty great day of the year 🙂 Great episode of TWiV as usual team.
I found nothing in the TWiV (first 37min) about whether Tamiflu works for prophylaxis.
We saw multiple papers that showed prophylactic effects of tamiflu i.e.
it was recommended for post-exposure prophylaxis (PEP) and that is
also the reason why most countries stockpiled it according to their pandemic plans.
And in 2006,2007 we had many reports of so-called “tamiflu-blankets” for H5N1,
where it was given prophylactically in regions with H5N1 outbreaks
to relatives, contacts of H5N1,H7N9 suspects.
Relenza, Laninamivir
Glad to see your group looking at evidence of the problem of corporate greed and secrecy added to a medical cocktail. There is a lot more evidence if you look.